Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 GBX | 0.00% | 0.00% | +9.52% |
04-17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
04-17 | BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment | MT |
Quotes 5-day view
Delayed Quote London S.E.07/05/2024 | 08/05/2024 | 09/05/2024 | 10/05/2024 | |
---|---|---|---|---|
Last | 11.5 p | 11.5 p | 11.5 p | 11.5 p |
Volume | 0 | 0 | 8 000 | 0 |
Change | 0.00% | 0.00% | 0.00% | 0.00% |
Opening | 11.50 | 11.50 | 11.50 | 11.50 |
High | 11.50 | 11.50 | 11.00 | 11.50 |
Low | 11.50 | 11.50 | 11.00 | 11.50 |
Performance
1 month | +2.22% | ||
6 months | -4.17% | ||
Current year | +9.52% | ||
1 year | -23.33% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | +9.52% | -23.33% | 11.88M | ||
-4.39% | -6.15% | +17.96% | -10.33% | 44.96B | ||
-0.04% | +1.27% | +48.77% | -7.00% | 41.85B | ||
+2.13% | +4.79% | +1.17% | +24.46% | 42.65B | ||
+1.69% | +2.88% | -4.27% | +12.28% | 29.04B | ||
+0.11% | +2.06% | +11.42% | +64.37% | 26.08B | ||
-0.59% | -1.22% | -21.39% | -28.68% | 19.03B | ||
+1.71% | +4.68% | +4.86% | -0.36% | 12.75B | ||
-2.26% | -0.61% | +27.29% | +85.66% | 12.06B | ||
-0.86% | -2.29% | -3.50% | +22.45% | 11.75B | ||
-0.67% | +0.71% | +20.18% | +24.51% | 11.72B | ||
+0.07% | +1.47% | -2.60% | -7.09% | 9.67B | ||
-1.51% | -0.46% | +15.68% | +97.85% | 6.68B | ||
+2.65% | +3.80% | +28.31% | -10.27% | 6.9B | ||
-0.10% | +0.98% | +8.59% | -30.93% | 6.7B | ||
-0.53% | -7.34% | +29.88% | +48.23% | 6.15B | ||
Average | -0.16% | -0.04% | +11.99% | +16.36% | ||
Weighted average by Cap. | -0.30% | +0.26% | +13.08% | +13.74% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.52% | ||
2023 | -38.24% | ||
2022 | -42.37% | ||
2021 | +15.69% |
- Stock Market
- Equities
- BVX Stock
- Quotes BiVictriX Therapeutics Plc